Galatea Bio Inc.
PrivateLast Round
Series A
Mar 27, 2025
Total Funding Raised
$25M
Company Overview
Galatea Bio Inc. operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a Series A round in March 2025.
Galatea Bio Inc. is a biotechnology company that advances precision medicine by using AI-driven data analytics and genomic research to improve diagnostic testing and accelerate drug discovery for diverse, underrepresented patient populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galatea Bio Inc. Comparables
Compare Galatea Bio Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allelica, Inc. | 80% | |
| Gen-t | 77% | |
| Dante Labs | 76% |
For institutional investors. Book with your work email.
Galatea Bio Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Galatea Bio Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helios Investment Partners | Series A |
| Founder Collective | Series A |
| Digitalis Ventures | Series A |
| Stanford University | Series A |
| F-Prime Capital | Series A |
| HBM Healthcare Investments | Series A |
| Alexandria Venture Investments | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2025
Developing genetic disease risk assays with Fabric Genomics.
- Jun 23, 2025
Partnered with Fabric Genomics to co-develop genetic disease risk assays.
For institutional investors. Book with your work email.
Galatea Bio Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Galatea Bio Inc.'s valuation, stock price, and market status.
Is Galatea Bio Inc. a public or private company?
Galatea Bio Inc. is a private company.
What is the current stock price of Galatea Bio Inc.?
Galatea Bio Inc. is a private company, so its shares have no public market price. Caplight tracks Galatea Bio Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Galatea Bio Inc. worth (valuation)?
Valuation information for Galatea Bio Inc. is not publicly available.
Can I buy Galatea Bio Inc. stock?
Galatea Bio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Galatea Bio Inc.'s last funding round?
Galatea Bio Inc.'s most recent funding round was Series A on March 27, 2025.
Who are the main investors in Galatea Bio Inc.?
Key investors in Galatea Bio Inc. include F-Prime Capital, F-Prime Capital.
Will Galatea Bio Inc. IPO soon?
No public IPO plans have been announced for Galatea Bio Inc..
How can I track Galatea Bio Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Galatea Bio Inc.'s shares on secondary markets.